Research areas
► government ethics and the regulation of health care (e.g., conflicts of interest, lobbying, revolving door, transparency)
► Food and Drug Administration (FDA)
► technologies (e.g., drugs, devices, AI, cybersecurity)
Metholodogical approach
► guided by economic and sociological theory
► quantitative (statistical / econometric) methods
► large administrative, survey, and other datasets
Recent Activity
>> Upcoming Health Affairs webinar <<
Tues, Feb 17, 2026: 8-9 am PT/11-12 noon ET
I’ll be joining Rachel Sachs (Wash U in St Louis), Holly Fernandez Lynch (UPenn), and Chris Meekins (Raymond James) to discuss FDA and Its Changing Relationship to Industry.
Contact me if you’d like an invitation.
>> New Publication <<
August 18, 2025
Conflicts of interest in federal vaccine advisory committees. [PDF] JAMA 2025. Online ahead of print.
>> New Publication <<
July 31, 2025
Impact of the MISSION Act on quality and outcomes of major cardiovascular procedures among veterans. JAMA 2025. Online ahead of print.
PharmaVoice
January 29, 2026
Politicization runs deeper than ever at FDA, risking long-term impacts
by Michael Gibney
MedPage Today
December 30, 2025
Five leaders in one year: FDA’s drug center enters 2026 at a crossroads
by Joedy McCreary